TET2 and myelodysplastic syndrome: Here, we found that TET2 mutation in NK cells from MDS patients, with or without additional mutated genes, does not seem to affect NK cells from the oncogenic point of view (i.e. NK cells were not leukemic) but alters their phenotype and function.